US Patent 9453222 Ligand-conjugated monomers

Patent 9453222 was granted and assigned to Alnylam Pharmaceuticals on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Alnylam Pharmaceuticals

Current Assignee

Alnylam Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94532220

Patent Inventor Names

Kallanthottathil G. Rajeev0

Muthiah Manoharan0

Venkitasamy Kesavan0

Date of Patent

September 27, 2016

Patent Application Number

145822840

Date Filed

December 24, 2014

Patent Citations Received

‌

US Patent 11879125 GalNAc compositions for improving siRNA bioavailability

Patent Primary Examiner

‌

Michael Barker

Patent abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9453222 Ligand-conjugated monomers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API